Publication Database
Dr. Constenla's diverse body of work ā encompassing peer-reviewed journals, reports, op-eds, and media publications ā provides evidence-based insights to inform health policy decisions, improve health outcomes, and reduce the economic burden of infectious diseases. Collaborating closely with decision-makers at local, national, and international levels ensures her research translates into real-world impact. Explore these publications below by themes. If you would like more information about these publications, please feel free to contact us.
Hydroclimate Health Economics: Peer-Reviewed Papers
Explores the intricate link between climate, weather, and disease patterns. Learn how economic tools can guide adaptation, mitigation, and strengthen health systems against climate threats. Our research focuses on vector-borne arboviral diseases, enteric and water-related infections, malaria, and climate-oriented vaccine financing and demand forecasting. We use a comprehensive approach, including micro-costing of direct, caregiver, and productivity losses, cost-effectiveness analysis, dynamic vaccine demand modeling, and the development of sustainable financing tools.
The economic impact of Aedes arboviruses and arbovirus vaccines: A review of the evidence
Read moreA review of the economic evidence of typhoid fever and typhoid conjugate vaccination and recommendations for future vaccine introduction decisions
Read moreForecasting demand for the typhoid conjugate vaccine in low- and middle-income countries
Read moreFeatures of dengue and Chikungunya infections of Colombian children under 24 months of age admitted to the emergency department
Read moreFinancing dengue vaccine introduction in the Americas: Challenges and opportunities
Read moreEconomic impact of dengue: Multicenter study across four Brazilian regions
Read moreCosting dengue fever cases and outbreaks: recommendations from a costing dengue working group in the Americas
Read moreAssessing the economics of dengue: results from a systematic review of the literature
Read moreEstimating the supply and demand of Butantan dengue vaccine In Brazil
Read moreAssessing economic benefits of vaccines based on the health investment life course framework: A review of a broader approach to evaluate malaria vaccination
Read moreNew chapter is unfolding in the fight against dengue with an unwritten ending
Read moreExpert consensus building in developing guidelines: lessons learned form a dengue economics workshop in the Americas
Read moreThe economic costs of malaria in children in three Sub-Saharan countries: Ghana, Tanzania and Kenya
Read moreCost of diarrhea in children under 5 in Uganda
Read moreCost of diarrhea in children under 5 in Bangladesh
Read moreHydroclimate Health Economics: Op-Eds and Media Publications
A Toxic Trade: The Afterlife of our Electronic Waste
Read moreClimate Change and Poverty: A Critical Connection
Read moreExploring the Economic Impact of Climate Change: Key Insights from 2020 to 2023
Read moreStorms on the Rise: Embracing the New Reality of Hurricanes Amidst Higher Temperatures
Read moreShielding Children from Heat Waves: A Health Priority
Read moreClimate Changeās Silent Victims: Women in Developing Countries
Read morePopulation Growth and Climate Change: Navigating our Global Future
Read moreClimate Change and Birth Registration
Read moreDengue in a Warming and Increasingly Wet World
Read moreFeeling the Burn: How Extreme Heat is Taking a Toll on our Health
Read moreEconomic Evaluations and Investment Analysis
Our publications provide data-driven insights for making informed health investment decisions. We utilize economic evaluations, where we compare the value of different interventions through cost-effectiveness, cost-utility, cost-benefit, and budget impact analyses. We also use investment analyses to assess the potential returns and risks associated with various health programs and initiatives. Explore the database to find research that can help you maximize the impact of your health investments.
15-year experience with rotavirus vaccination in Mexico: A systematic literature review
Read moreContingent Valuation: A pilot study for eliciting willingness to pay for a reduction in mortality from vaccine-preventable illnesses for children and adults in Bangladesh
Read moreBudget impact analysis of pneumococcal conjugate vaccines in Colombia
Read moreCosts of immunization programs for 10 vaccines in 94 low- and middle-income countries from 2011-2030
Read moreReturn on Investment from Immunization Programs Against 10 Pathogens in 94 Low- and Middle-Income Countries from 2011-2030
Read moreThe economic impact of Aedes arboviruses and arbovirus vaccines: A review of the evidence
Read moreScoping review of investment cases for vaccines and immunization programs
Read moreEstimating the value of pneumococcal conjugate, haemophilus influenzae type b and rotavirus vaccination in India
Read moreA review of the economic evidence of typhoid fever and typhoid conjugate vaccination and recommendations for future vaccine introduction decisions
Read moreForecasting demand for the typhoid conjugate vaccine in low- and middle-income countries
Read morePoverty reduction and equity benefits from the introduction or scaling up of measles, rotavirus and pneumococcal vaccines in low- and middle-income countries: findings from a modeling study
Read moreThe equity impact vaccines may have on averting deaths and medical impoverishment in developing countries
Read moreGeospatial planning and the resulting economic impact of Human Papillomavirus Vaccine introduction in Mozambique
Read moreDecision-Tree Model for Support of Health Policy Choices Based on Pneumococcal Conjugate Vaccine (PCV) Program Outcomes
Read moreThe economic value of increasing geospatial access to tetanus toxoid immunization in Mozambique
Read moreFinancing dengue vaccine introduction in the Americas: Challenges and opportunities
Read moreExploring variation in cost-effectiveness estimates in studies that evaluate adult pneumococcal vaccination in Latin America
Read morePost-introduction economic evaluation of pneumococcal conjugate vaccination in Ecuador, Honduras and Paraguay
Read moreEconomic impact of meningococcal outbreaks in Brazil and Colombia
Read moreEconomic impact of dengue: multicenter study across four Brazilian regions
Read moreCosting dengue fever cases and outbreaks: recommendations from a costing dengue working group in the Americas
Read moreAssessing the economics of dengue: results from a systematic review of the literature
Read moreEstimating the supply and demand of Butantan dengue vaccine In Brazil
Read moreAssessing economic benefits of vaccines based on the health investment life course framework: A review of a broader approach to evaluate malaria vaccination
Read moreIs the world ready for an Ebola vaccine?
Read moreCost-effectiveness of a quality improvement programme to reduce central line associated bloodstream infections in intensive care units in the USA
Read moreEstimating the costs associated with a community outbreak of meningococcal disease in a Colombian Caribbean City
Read moreReassessing the value of vaccines
Read moreExpert consensus building in developing guidelines: Lessons learned form a dengue economics workshop in the Americas
Read moreThe economic costs of malaria in children in three Sub-Saharan countries: Ghana, Tanzania and Kenya
Read moreIdentifying unit costs for use in regional economic evaluation: An example of an economic analysis of childhood pneumococcal conjugate vaccine in Latin America and the Caribbean
Read moreEstimating the cost-effectiveness of pneumococcal conjugate vaccination in Brazil
Read moreEconomic impact of a rotavirus vaccination program in Mexico
Read moreEconomic impact of a rotavirus vaccine in Brazil
Read moreThe cost-effectiveness of pneumococcal conjugate vaccine in Latin American and the Caribbean: A regional analysis
Read moreEconomic impact of pneumococcal conjugate vaccination in Brazil, Chile, and Uruguay
Read morePotential cost-effectiveness of vaccination for rotavirus gastroenteritis in Latin America
Read moreCost-effectiveness analysis of rotavirus vaccine in Chile
Read moreEconomic impact and cost-effectiveness analysis of rotavirus vaccine in Venezuela
Read moreUse of various methods for cost estimation in multi-national economic evaluations
Read moreThe value of medicines: is there enough economic evidence?
Read moreDisease Burden and Cost-of-Illness Studies: Peer-Reviewed Papers
We have extensive expertise in quantifying the economic burden of disease in low- and middle-income countries, serving as a vital resource for shaping effective healthcare policy. Our systematic approach provides reliable results through rigorous, standardized data collection and analysis, cross-regional insights, and comparative analyses of disease prevalence and costs across multiple regions. We also offer actionable guidance with clear recommendations for resource allocation, policy development, and intervention strategies.
The economic burden of pneumonia in children under five in Uganda
Read moreThe economic burden of measles in children under five in Bangladesh
Read moreThe economic burden of measles in children under five in Uganda
Read moreContingent Valuation: A pilot study for eliciting willingness to pay for a reduction in mortality from vaccine-preventable illnesses for children and adults in Bangladesh
Read moreThe cost of eight pediatric infectious illnesses in low- and middle-income countries: A systematic review of cost of illness studies.
Read moreCosts of immunization programs for 10 vaccines in 94 low- and middle-income countries from 2011-2030
Read moreEstimating the costs of invasive pneumococcal disease in older children and adults in selected countries of Latin America
Read moreEstimating the opportunity costs of treating meningitis in selected countries of Latin America
Read moreCosting dengue fever cases and outbreaks: recommendations from a costing dengue working group in the Americas
Read moreEstimating the costs associated with a community outbreak of meningococcal disease in a Colombian Caribbean City
Read moreThe economic costs of malaria in children in three Sub-Saharan countries: Ghana, Tanzania and Kenya
Read moreIdentifying unit costs for use in regional economic evaluation: An example of an economic analysis of childhood pneumococcal conjugate vaccine in Latin America and the Caribbean
Read moreEvaluating the costs of pneumococcal disease in selected Latin American countries
Read moreEconomic and health burden of rotavirus gastroenteritis in eight Latin American and Caribbean countries
Read moreUse of various methods for cost estimation in multi-national economic evaluations
Read moreDisease Burden and Cost-of-Illness Studies: Op-Eds and Media Publications
Understanding the costs of Pneumonia, Diarrhea, and Measles in Uganda - The Decade of Vaccine Economics study reveals significant household costs associated with childhood diseases
Read morePneumonia, diarrhea and measles force Bangladeshi households to make difficult financial decision when illness arise
Read moreDOVE-IV: Measuring the cost of illness
Read moreMeasuring the cost of childhood diseases ā laying the groundwork for countries in Asia to establish a viable plan for standardized data collection, data entry and data monitoring procedures
Read moreUnderstanding the financial toll of childhood illness
Read moreWhat is the financial toll of common childhood illness?
Read moreThe potential economic impact of the Zika virus
Read moreCosting dengue cases and outbreaks: A guide to current Practices and Procedures
Read more